Krensavage Asset Management’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-70,263
Closed -$89K 16
2025
Q1
$89K Buy
70,263
+100
+0.1% +$365 0.05% 14
2024
Q4
$226K Sell
70,163
-5,705
-8% -$20.1K 0.13% 12
2024
Q3
$237K Buy
75,868
+811
+1% +$2.64K 0.13% 13
2024
Q2
$236K Sell
75,057
-12,944
-15% -$47.7K 0.11% 13
2024
Q1
$430K Sell
88,001
-2,832
-3% -$13.7K 0.19% 12
2023
Q4
$538K Buy
+90,833
New +$365K 0.19% 12

Other funds holding MURA

Krensavage Asset Management's MURA Position: Q2 2025 in Review

Krensavage Asset Management sold out of Mural Oncology (MURA) in Q2 2025, closing a stake of 70,263 shares — an estimated $89K sold.

Krensavage Asset Management first reported a position in MURA in Q4 2023 and held it in 6 quarters. The position peaked at $538K in Q4 2023. 66 funds tracked by Wall St. Rank hold MURA as of Q2 2025.

  • Krensavage Asset Management reported no remaining Mural Oncology position as of Q2 2025 after selling out during the quarter.
  • Krensavage Asset Management sold 70,263 Mural Oncology shares in Q2 2025, an estimated $89K.
  • Krensavage Asset Management first reported a position in Mural Oncology in Q4 2023 and held it in 6 quarters.
  • Krensavage Asset Management's Mural Oncology position peaked at $538K in Q4 2023.
  • 66 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2025.

Based on Krensavage Asset Management's 13F filing for Q2 2025, filed 15 Aug 2025.